Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review

Date: November 22, 2016
Pages: 45
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ACE110A2313EN
Leaflet:

Download PDF Leaflet

Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review
Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturing capabilities cover a range of product-types including oral solid dose, semi-solids, liquids, steriles, biological, active pharmaceutical ingredients (APIs) and infant nutritionals. Aspen has manufacturing facilities on six continents. It has presence in emerging countries (including Sub-Saharan Africa, Latin America, South East Asia, Eastern Europe and the Commonwealth of Independent States) and developed countries (principally Western Europe). Aspen is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings Ltd Key Recent Developments

Sep 14, 2016: Aspens comparable revenue increases by 12% to R35.4 billion
Mar 03, 2016: Aspen’s profit after tax increases by 35%
Sep 09, 2015: Aspen’s revenue increases 22% to R36 billion
Mar 05, 2015: Aspen’s half-year gross revenue surges by 47% to R19 billion

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Aspen Pharmacare Holdings Ltd - Key Facts
Aspen Pharmacare Holdings Ltd - Key Employees
Aspen Pharmacare Holdings Ltd - Key Employee Biographies
Aspen Pharmacare Holdings Ltd - Major Products and Services
Aspen Pharmacare Holdings Ltd - History
Aspen Pharmacare Holdings Ltd - Company Statement
Aspen Pharmacare Holdings Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Aspen Pharmacare Holdings Ltd - Business Description
Aspen Pharmacare Holdings Ltd - Corporate Strategy
Aspen Pharmacare Holdings Ltd - SWOT Analysis
SWOT Analysis - Overview
Aspen Pharmacare Holdings Ltd - Strengths
Aspen Pharmacare Holdings Ltd - Weaknesses
Aspen Pharmacare Holdings Ltd - Opportunities
Aspen Pharmacare Holdings Ltd - Threats
Aspen Pharmacare Holdings Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Aspen Pharmacare Holdings Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 14, 2016: Aspens comparable revenue increases by 12% to R35.4 billion
Mar 03, 2016: Aspen’s profit after tax increases by 35%
Sep 09, 2015: Aspen’s revenue increases 22% to R36 billion
Mar 05, 2015: Aspen’s half-year gross revenue surges by 47% to R19 billion

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Aspen Pharmacare Holdings Ltd, Key Facts
Aspen Pharmacare Holdings Ltd, Key Employees
Aspen Pharmacare Holdings Ltd, Key Employee Biographies
Aspen Pharmacare Holdings Ltd, Major Products and Services
Aspen Pharmacare Holdings Ltd, History
Aspen Pharmacare Holdings Ltd, Other Locations
Aspen Pharmacare Holdings Ltd, Subsidiaries
Aspen Pharmacare Holdings Ltd, Joint Venture
Aspen Pharmacare Holdings Ltd, Key Competitors
Aspen Pharmacare Holdings Ltd, Ratios based on current share price
Aspen Pharmacare Holdings Ltd, Annual Ratios
Aspen Pharmacare Holdings Ltd (Cont...1), Annual Ratios
Aspen Pharmacare Holdings Ltd, Interim Ratios
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Aspen Pharmacare Holdings Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Aspen Pharmacare Holdings Ltd, Performance Chart (2012 - 2016)
Aspen Pharmacare Holdings Ltd, Ratio Charts
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Pfizer Inc
Novartis AG
Merck & Co Inc
Baxter International Inc
AstraZeneca Plc
Adcock Ingram Holdings Ltd
Skip to top


Ask Your Question

Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: